📰 Abt News
Page 59 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
December 18, 2023
Acropolis Investment Management LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,060 shares of the healthcare product maker’s stock after selling 208 shares during the quarter. […]
December 18, 2023
Alera Investment Advisors LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 39.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,559 shares of the healthcare product maker’s stock after buying an additional 1,841 shares during the quarter. Alera Investment Advisors […]
December 17, 2023
National Bank of Canada FI lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.0% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,059,742 shares of the healthcare product maker’s stock after acquiring an additional 50,306 shares during the period. National Bank of Canada FI’s holdings in Abbott Laboratories […]
December 17, 2023
Arcblock (ABT) traded 2.3% lower against the U.S. dollar during the 1 day period ending at 23:00 PM ET on December 16th. One Arcblock token can currently be bought for approximately $0.23 or 0.00000555 BTC on cryptocurrency exchanges. In the last seven days, Arcblock has traded up 86.5% against the U.S. dollar. Arcblock has a […]
December 17, 2023
Founders Capital Management cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 748 shares of the healthcare product maker’s stock after selling 325 shares during the quarter. Founders Capital Management’s holdings in Abbott Laboratories were worth $72,000 at the end of […]
December 17, 2023
WBH Advisory Inc. lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,932 shares of the healthcare product maker’s stock after selling 121 shares during the […]
December 17, 2023
National Bank of Canada FI boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 5.0% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,059,742 shares of the healthcare product maker’s stock after purchasing an additional 50,306 shares during the period. National Bank of Canada […]
December 17, 2023
Symmetry Partners LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 9,067 shares of the healthcare product maker’s stock, valued at approximately $878,000. A number of other institutional investors and […]
December 17, 2023
MADDEN SECURITIES Corp increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,450 shares of the healthcare product maker’s stock after buying an additional 150 shares during the period. MADDEN SECURITIES Corp’s […]
December 17, 2023
Founders Capital Management reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 748 shares of the healthcare product maker’s stock after selling 325 shares during the quarter. […]